Covid19_manual_annotation  

2020PubMed@AikoHIRAKI:33706041 JSONTXT

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue tao:has_database_id
T16 37-42 Glycan denotes blood https://glytoucan.org/Structures/Glycans/G00068MO
T12 37-49 Glycan denotes blood type A https://glytoucan.org/Structures/Glycans/G00066MO
T22 53-69 PositiveRegulation denotes over-represented
T13 74-80 Glycan denotes type O https://glytoucan.org/Structures/Glycans/G00068MO
T23 81-98 NegativeRegulation denotes under-represented
T3 105-113 Disease denotes COVID-19 MESH:D000086382
T24 114-122 Species denotes patients Tax:9606
T4 114-122 Species denotes patients Tax:9606
T21 133-153 Biological denotes blood group antigens MESH:D001789
T25 325-335 Number denotes prevalence MESH:D015995
T30 379-380 Glycan denotes A https://glytoucan.org/Structures/Glycans/G00066MO
T32 380-381 Glycan denotes B https://glytoucan.org/Structures/Glycans/G47548GA
T29 381-382 Glycan denotes O https://glytoucan.org/Structures/Glycans/G00068MO
T28 383-394 Biological denotes transfusion MESH:D001803
T6 435-442 Species denotes patient Tax:9606
T49 460-465 Species denotes virus
T36 505-512 Area denotes Western
T17 525-531 Glycan denotes type A https://glytoucan.org/Structures/Glycans/G00066MO
T31 536-538 Glycan denotes AB https://glytoucan.org/Structures/Glycans/G00066MO|https://glytoucan.org/Structures/Glycans/G47548GA
T14 580-586 Glycan denotes type O https://glytoucan.org/Structures/Glycans/G00068MO
T38 669-677 Epidemic denotes epidemic MESH:D058872
T19 756-762 Glycan denotes type A https://glytoucan.org/Structures/Glycans/G00066MO
T33 763-765 Glycan denotes AB https://glytoucan.org/Structures/Glycans/G00066MO|https://glytoucan.org/Structures/Glycans/G47548GA
T7 766-774 Species denotes patients Tax:9606
T40 806-818 Timing denotes early stages
T39 826-834 Epidemic denotes epidemic MESH:D058872
T8 890-898 Disease denotes infected MESH:D007239
T9 973-981 Disease denotes COVID-19 MESH:D000086382
T26 982-992 Number denotes prevalence MESH:D015995
T41 1013-1025 Timing denotes early stages
T10 1033-1043 Species denotes SARS-CoV-2 Tax:2697049
T37 1044-1052 Epidemic denotes epidemic MESH:D058872
T34 1093-1094 Glycan denotes A https://glytoucan.org/Structures/Glycans/G00066MO
T42 1094-1095 Glycan denotes B https://glytoucan.org/Structures/Glycans/G47548GA
T43 1095-1096 Glycan denotes O https://glytoucan.org/Structures/Glycans/G00068MO
T50 1121-1126 Species denotes virus
T20 1307-1313 Glycan denotes type A https://glytoucan.org/Structures/Glycans/G00066MO
T35 1314-1316 Glycan denotes AB https://glytoucan.org/Structures/Glycans/G00066MO|https://glytoucan.org/Structures/Glycans/G47548GA
T15 1337-1343 Glycan denotes type O https://glytoucan.org/Structures/Glycans/G00068MO
T45 1379-1385 Type denotes random
T44 1386-1397 Therapy denotes vaccination MESH:D014611
T46 1401-1409 NegativeRegulation denotes blocking
T47 1410-1419 Species denotes community Tax:9606
T51 1420-1426 Disease denotes spread MESH:D007239
T48 1434-1439 Species denotes virus
T27 1617-1627 Number denotes prevalence MESH:D015995
R1 T16 T13 - blood,type O
R10 T51 T47 has_a spread,community
R11 T48 T51 cause_of virus,spread
R12 T44 T46 is_a vaccination,blocking
R13 T45 T44 of_a random,vaccination
R14 T46 T47 is_a blocking,community
R2 T3 T4 has_a COVID-19,patients
R3 T3 T24 has_a COVID-19,patients
R4 T12 T22 is_a blood type A,over-represented
R5 T22 T4 is_a over-represented,patients
R6 T16 T23 is_a blood,under-represented
R7 T23 T24 is_a under-represented,patients
R8 T40 T39 of_a early stages,epidemic
R9 T51 T8 coreference spread,infected